Published on in Vol 7, No 3 (2018): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/9192, first published .
Symptomatic Treatment of Vascular Cognitive Impairment (STREAM-VCI): Protocol for a Cross-Over Trial

Symptomatic Treatment of Vascular Cognitive Impairment (STREAM-VCI): Protocol for a Cross-Over Trial

Symptomatic Treatment of Vascular Cognitive Impairment (STREAM-VCI): Protocol for a Cross-Over Trial

Journals

  1. Leijenaar J, Groeneveld G, Klaassen E, Leeuwis A, Scheltens P, Weinstein H, van Gerven J, Barkhof F, van der Flier W, Prins N. Methylphenidate and galantamine in patients with vascular cognitive impairment–the proof-of-principle study STREAM-VCI. Alzheimer's Research & Therapy 2020;12(1) View
  2. Leijenaar J, Ingala S, Sudre C, Mutsaerts H, Leeuwis A, van der Flier W, Scheltens P, Weinstein H, Barkhof F, van Gerven J, Groeneveld G, Prins N. Decreased integrity of the monoaminergic tract is associated with a positive response to MPH in patients with vascular cognitive impairment - proof of principle study STREAM-VCI. Cerebral Circulation - Cognition and Behavior 2022;3:100128 View

Books/Policy Documents

  1. Berthier M, Dávila G, Edelkraut L, López-Barroso D, Torres-Prioris M, Tubío-Ordónez J. Neurovascular Neuropsychology. View